プロピオン酸血症の世界市場レポート 2025年

プロピオン酸血症の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.4％で24億9,000万米ドルに成長します。予測期間中に予測される成長は、認知度向上キャンペーンの拡大、代謝異常症例数の増加、遠隔医療の採用拡大、個別化治療に対する需要の高まり、ヘルスケア投資の増加などの要因によるものです。この期間に予想される主な動向には、診断の技術的進歩、遺伝子治療の開発、代謝治療の革新、ヘルスケアにおけるAIの統合、新規治療薬の創出などが含まれます。

遺伝子疾患の有病率の増加は、プロピオン酸血症市場の成長を促進すると予想されます。遺伝性疾患は、個人のDNAの変異や異常によって引き起こされる病態であり、遺伝する場合もあれば自然に発生する場合もあり、健康や開発に影響を与えます。遺伝性疾患の増加の主な要因の一つは、劣性遺伝子の突然変異を受け継ぐ可能性を高める近親婚です。これは、欠陥のある遺伝子が両親から受け継がれることで発生し、遺伝的疾患のリスクを著しく高める。プロピオン酸血症は、代謝の不均衡に対処し、患者の転帰を改善する標的治療を提供することで、遺伝性疾患の管理に重要な役割を果たしています。例えば、2022年7月、米国の非営利団体である嚢胞性線維症（CF）財団が発表した報告書によると、嚢胞性線維症の有病率は増加しており、2022年には米国で約4万人の子供と成人が罹患し、世界全体では10万5千人以上が診断されています。その結果、遺伝性疾患の有病率の増加がプロピオン酸血症市場の拡大に拍車をかけています。

プロピオン酸血症市場の主要企業は、疾患の遺伝的原因を直接標的とする革新的なmRNAベースの治療法の開発に注力しています。mRNA治療法は、メッセンジャーRNAを使用して、遺伝子レベルで疾患を予防または治療できるタンパク質の産生を細胞に指示することで機能します。例えば、2023年5月、米国の製薬・バイオテクノロジー企業であるModerna社は、プロピオン酸血症に対する治験用mRNA療法であるmRNA-3927の第1/2相試験の中間データを発表しました。この治療法は、mRNAを介してPCCAおよびPCCB遺伝子の機能的コピーを送達し、肝臓の酵素活性を回復させ、代謝性機能低下を抑制する可能性があります。この最先端のアプローチは、疾患の遺伝的根本原因に対処することで患者の転帰を改善し、この稀な代謝性疾患に罹患している人々に新たな希望を提供することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のプロピオン酸血症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のプロピオン酸血症市場：成長率分析
• 世界のプロピオン酸血症市場の実績：規模と成長, 2019-2024
• 世界のプロピオン酸血症市場の予測：規模と成長, 2024-2029, 2034F
• 世界のプロピオン酸血症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のプロピオン酸血症市場：薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• L-カルニチン
• 抗生物質
• 世界のプロピオン酸血症市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 静脈内
• 筋肉内
• 世界のプロピオン酸血症市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のプロピオン酸血症市場：タイプ別サブセグメンテーション、L-カルニチン、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 注射剤
• 世界のプロピオン酸血症市場：タイプ別サブセグメンテーション、抗生物質、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 注射剤

第7章 地域別・国別分析

• 世界のプロピオン酸血症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のプロピオン酸血症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• プロピオン酸血症市場：競合情勢
• プロピオン酸血症市場：企業プロファイル
  • Moderna Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • Synlogic Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Global Calcium Overview, Products and Services, Strategy and Financial Analysis
  • BridgeBio Pharma Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AdvaCare Pharma
• HemoShear Therapeutics
• DNA Labs
• Velnex Medicare
• Phytologix Life Scieneces
• Liaoning Koncepnutra Co. Ltd.
• Propionic Acidemia Foundation
• Agex Pharma
• Gladfem
• CSL Behring
• Octapharma AG
• Sanquin
• Kedrion SpA
• Shire plc
• Vitane Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• プロピオン酸血症市場2029：新たな機会を提供する国
• プロピオン酸血症市場2029：新たな機会を提供するセグメント
• プロピオン酸血症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Propionic acidemia (PA) is a rare inherited metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, which is crucial for breaking down specific amino acids and fatty acids. This deficiency results in the accumulation of toxic compounds in the blood, leading to severe symptoms such as metabolic crises and neurological damage. If left untreated, the condition can be life-threatening, particularly during infancy.

The primary drug classes used for treating propionic acidemia include L-carnitine and antibiotics. L-Carnitine is a naturally occurring compound that plays a vital role in transporting long-chain fatty acids into mitochondria, where they undergo oxidation to generate energy. Treatment can be administered through various routes, including oral, intravenous, and intramuscular methods. These medications are distributed through multiple channels, such as hospital pharmacies, retail pharmacies, and online pharmacies.

The propionic acidemia market research report is one of a series of new reports from The Business Research Company that provides propionic acidemia market statistics, including propionic acidemia industry global market size, regional shares, competitors with a propionic acidemia market share, detailed propionic acidemia market segments, market trends and opportunities, and any further data you may need to thrive in the propionic acidemia industry. This propionic acidemia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The propionic acidemia market size has grown steadily in recent years. It will grow from $2.00 billion in 2024 to $2.09 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth during the historic period can be attributed to factors such as the increasing prevalence of the disease, expansion of newborn screening programs, rising healthcare expenditures, a higher rate of pediatric diagnoses, and the advancement of rare disease initiatives.

The propionic acidemia market size is expected to see steady growth in the next few years. It will grow to $2.49 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The projected growth during the forecast period can be attributed to factors such as expanding awareness campaigns, a rising number of metabolic disorder cases, increased adoption of telemedicine, growing demand for personalized treatments, and increased healthcare investments. Key trends expected in this period include technological advancements in diagnostics, the development of gene therapies, innovations in metabolic treatments, the integration of AI in healthcare, and the creation of novel therapeutics.

The increasing prevalence of genetic disorders is expected to drive the growth of the propionic acidemia market. Genetic disorders are conditions caused by mutations or abnormalities in an individual's DNA, which may be inherited or occur spontaneously, impacting health and development. One of the key factors contributing to the rise in genetic disorders is consanguineous marriages, which increase the likelihood of inheriting recessive genetic mutations. This occurs when defective genes are passed down from both parents, significantly raising the risk of genetic conditions. Propionic acidemia plays a crucial role in managing genetic disorders by providing targeted treatments that address metabolic imbalances and improve patient outcomes. For example, in July 2022, a report published by the Cystic Fibrosis (CF) Foundation, a US-based non-profit organization, indicated that the prevalence of cystic fibrosis had increased, affecting nearly 40,000 children and adults in the United States in 2022, with over 105,000 individuals diagnosed globally. Consequently, the growing prevalence of genetic disorders is fueling the expansion of the propionic acidemia market.

Leading companies in the propionic acidemia market are focusing on the development of innovative mRNA-based treatments to directly target the genetic causes of the disease. mRNA therapies function by using messenger RNA to instruct cells to produce proteins that can prevent or treat diseases at the genetic level. For example, in May 2023, Moderna, a US-based pharmaceutical and biotechnology company, shared interim data from the Phase 1/2 trial of mRNA-3927, an investigational mRNA therapy for propionic acidemia. This therapy delivers functional copies of the PCCA and PCCB genes via mRNA, restoring enzyme activity in the liver and potentially reducing metabolic decompensations. This cutting-edge approach aims to enhance patient outcomes by addressing the genetic root cause of the disease, offering new hope for those affected by this rare metabolic disorder.

In May 2023, Ironwood Pharmaceuticals Inc., a US-based biotechnology company, acquired VectivBio for approximately $1 billion. Through this acquisition, Ironwood aims to strengthen its pipeline for rare diseases by integrating VectivBio's innovative therapies, including investigational treatments for propionic acidemia. VectivBio, a Switzerland-based biotechnology company, specializes in developing treatments for rare gastrointestinal and metabolic disorders.

Major players in the propionic acidemia market are Moderna Therapeutics, Synlogic Therapeutics, Invitae Corporation, Global Calcium, BridgeBio Pharma, AdvaCare Pharma, HemoShear Therapeutics, DNA Labs, Velnex Medicare, Phytologix Life Scieneces, Liaoning Koncepnutra Co. Ltd., Propionic Acidemia Foundation, Agex Pharma, Gladfem, CSL Behring, Octapharma AG, Sanquin, Kedrion SpA, Shire plc, Vitane Pharmaceuticals Inc.

North America was the largest region in the propionic acidemia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in propionic acidemia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the propionic acidemia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The propionic acidemia market includes revenues earned by entities through enzyme replacement therapy (ERT), nutritional therapy services, personalized care management services, patient support programs, and pharmacogenomic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Propionic Acidemia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on propionic acidemia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for propionic acidemia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The propionic acidemia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: L-Carnitine; Antibiotics
• 2) By Route of Administration: Oral; Intravenous; Intramuscular
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Sub Segments:
• 1) By L-Carnitine Drug Class: Oral L-Carnitine; Injectable L-Carnitine
• 2) By Antibiotics Drug Class: Oral Antibiotics; Injectable Antibiotics
• Companies Mentioned: Moderna Therapeutics; Synlogic Therapeutics; Invitae Corporation; Global Calcium; BridgeBio Pharma
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Propionic Acidemia Market Characteristics

3. Propionic Acidemia Market Trends And Strategies

4. Propionic Acidemia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Propionic Acidemia Growth Analysis And Strategic Analysis Framework

• 5.1. Global Propionic Acidemia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Propionic Acidemia Market Growth Rate Analysis
• 5.4. Global Propionic Acidemia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Propionic Acidemia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Propionic Acidemia Total Addressable Market (TAM)

6. Propionic Acidemia Market Segmentation

• 6.1. Global Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• L-Carnitine
• Antibiotics
• 6.2. Global Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Intramuscular
• 6.3. Global Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Propionic Acidemia Market, Sub-Segmentation Of L-Carnitine, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• 6.5. Global Propionic Acidemia Market, Sub-Segmentation Of Antibiotics, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable

7. Propionic Acidemia Market Regional And Country Analysis

• 7.1. Global Propionic Acidemia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Propionic Acidemia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Propionic Acidemia Market

• 8.1. Asia-Pacific Propionic Acidemia Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Propionic Acidemia Market

• 9.1. China Propionic Acidemia Market Overview
• 9.2. China Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Propionic Acidemia Market

• 10.1. India Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Propionic Acidemia Market

• 11.1. Japan Propionic Acidemia Market Overview
• 11.2. Japan Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Propionic Acidemia Market

• 12.1. Australia Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Propionic Acidemia Market

• 13.1. Indonesia Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Propionic Acidemia Market

• 14.1. South Korea Propionic Acidemia Market Overview
• 14.2. South Korea Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Propionic Acidemia Market

• 15.1. Western Europe Propionic Acidemia Market Overview
• 15.2. Western Europe Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Propionic Acidemia Market

• 16.1. UK Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Propionic Acidemia Market

• 17.1. Germany Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Propionic Acidemia Market

• 18.1. France Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Propionic Acidemia Market

• 19.1. Italy Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Propionic Acidemia Market

• 20.1. Spain Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Propionic Acidemia Market

• 21.1. Eastern Europe Propionic Acidemia Market Overview
• 21.2. Eastern Europe Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Propionic Acidemia Market

• 22.1. Russia Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Propionic Acidemia Market

• 23.1. North America Propionic Acidemia Market Overview
• 23.2. North America Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Propionic Acidemia Market

• 24.1. USA Propionic Acidemia Market Overview
• 24.2. USA Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Propionic Acidemia Market

• 25.1. Canada Propionic Acidemia Market Overview
• 25.2. Canada Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Propionic Acidemia Market

• 26.1. South America Propionic Acidemia Market Overview
• 26.2. South America Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Propionic Acidemia Market

• 27.1. Brazil Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Propionic Acidemia Market

• 28.1. Middle East Propionic Acidemia Market Overview
• 28.2. Middle East Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Propionic Acidemia Market

• 29.1. Africa Propionic Acidemia Market Overview
• 29.2. Africa Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Propionic Acidemia Market Competitive Landscape And Company Profiles

• 30.1. Propionic Acidemia Market Competitive Landscape
• 30.2. Propionic Acidemia Market Company Profiles
  • 30.2.1. Moderna Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Synlogic Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Global Calcium Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. BridgeBio Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Propionic Acidemia Market Other Major And Innovative Companies

• 31.1. AdvaCare Pharma
• 31.2. HemoShear Therapeutics
• 31.3. DNA Labs
• 31.4. Velnex Medicare
• 31.5. Phytologix Life Scieneces
• 31.6. Liaoning Koncepnutra Co. Ltd.
• 31.7. Propionic Acidemia Foundation
• 31.8. Agex Pharma
• 31.9. Gladfem
• 31.10. CSL Behring
• 31.11. Octapharma AG
• 31.12. Sanquin
• 31.13. Kedrion SpA
• 31.14. Shire plc
• 31.15. Vitane Pharmaceuticals Inc.

32. Global Propionic Acidemia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Propionic Acidemia Market

34. Recent Developments In The Propionic Acidemia Market

35. Propionic Acidemia Market High Potential Countries, Segments and Strategies

• 35.1 Propionic Acidemia Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Propionic Acidemia Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Propionic Acidemia Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer